RUNX2 and gastric cancer: JQ1, a BRD4 inhibitor, potently inhibited of the cell growth and malignant progression of GC by downregulating chromatin accessibility and inactivating the RUNX2/NID1 signaling pathway (Zhou et al., 2020).